Diagomet Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -87.04%
- Profit Growth -78.59%
- Ebitda -55.37%
- Net Worth 2.21%
- Total Assets -31.57%
About Diagomet Laboratories
Diagomet Laboratories Private Limited (DLPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 August 2014 and has a history of Ten years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vipin Nagpal, Dharni Kant, and Gavita Jha serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85195DL2014PTC270502
-
Company No.
270502
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Aug 2014
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Diagomet Laboratories?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipin Nagpal
|
Director | 19-Aug-2014 | Current |
|
Dharni Kant
|
Director | 19-Aug-2014 | Current |
|
Gavita Jha
|
Additional Director | 30-Sep-2020 | Current |
Financial Performance of Diagomet Laboratories.
Diagomet Laboratories Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 87.04% decrease. The company also saw a substantial fall in profitability, with a 78.59% decrease in profit. The company's net worth moved up by a moderate rise of 2.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diagomet Laboratories?
In 2021, Diagomet Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dgchem Labs Private LimitedDharni Kant and Gavita Jha are mutual person
-
Amrav Bakes LlpVipin Nagpal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diagomet Laboratories?
Unlock and access historical data on people associated with Diagomet Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diagomet Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diagomet Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
